Status:
COMPLETED
Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells
Lead Sponsor:
Slagelse Hospital
Collaborating Sponsors:
Skane University Hospital
Lund University
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal c...
Detailed Description
Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml sterile water. Fl...
Eligibility Criteria
Inclusion
- Surgery at Slagelse Hospital for rectal cancer with transanal mesorectal excision
- Consent to participate in the study
Exclusion
- No consent to participate
- No surgery
Key Trial Info
Start Date :
February 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 9 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04730102
Start Date
February 13 2020
End Date
February 9 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Slagelse Hospital
Slagelse, Region Sjælland, Denmark, 4200